Black Diamond Therapeutics
Angella A. is a seasoned clinical trial professional with extensive experience in managing clinical trials within the biopharmaceutical sector. Currently serving as a Senior Clinical Trial Manager at Black Diamond Therapeutics since November 2022, Angella has previously held positions as a Clinical Trial Manager and Sr. Clinical Trial Associate in the same organization. Prior to this role, Angella worked at Rubius Therapeutics as a Clinical Trial Associate and at Dana-Farber Cancer Institute as a Clinical Research Coordinator. Angella holds a Bachelor of Science degree in Pre-Medicine/Pre-Medical Studies from Framingham State University, earned between 2014 and 2018.
This person is not in any teams
This person is not in any offices
Black Diamond Therapeutics
3 followers
Black Diamond Therapeutics is a leading venture-backed biotechnology company focused on the discovery and development of precision medicines for cancer that are directed against a novel class of allosteric mutant oncogenes.